(19)
(11) EP 1 242 120 A2

(12)

(88) Date of publication A3:
28.02.2002

(43) Date of publication:
25.09.2002 Bulletin 2002/39

(21) Application number: 00981550.7

(22) Date of filing: 21.12.2000
(51) International Patent Classification (IPC)7A61K 45/06, A61P 17/02
(86) International application number:
PCT/IB0001/935
(87) International publication number:
WO 0104/9309 (12.07.2001 Gazette 2001/28)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.12.1999 GB 9930768

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)
  • PFIZER INC.
    New York, N.Y. 10017 (US)

(72) Inventors:
  • DAVIES, Michael John
    Kent CT13 9NJ (GB)
  • HUGGINS, Jonathan Paul
    Kent CT13 9NJ (GB)
  • MCINTOSH, Fraser Stuart
    Kent CT13 9NJ (GB)
  • OCCLESTON, Nicholas Laurence
    Kent CT13 9NJ (GB)

(74) Representative: Motion, Keith Robert et al
Pfizer LimitedPatents DepartmentRamsgate Road
Sandwich,Kent CT13 9NJ
Sandwich,Kent CT13 9NJ (GB)

   


(54) COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE